Quest Diagnostics stock trades down slightly near annual highs amid overbought technicals

Traders Union
All News
Companies
Quest Diagnostics slips 0.32% today

Highlights

DGX trades in a strong bullish structure, holding well above key short, medium, and long-term support levels.
Momentum and trend indicators remain predominantly bullish, though several signals suggest the stock is approaching overbought conditions.
For the coming week, DGX is expected to consolidate near $210.16–$216.64, with a bullish breakout above $213.50 potentially accelerating gains.

Bullish bias as price holds above multi-timeframe support

DGX is trading at $211.95, well above its MA-20 ($200.32), MA-50 ($196.13), and MA-200 ($190.25), indicating a strong bullish structure across the short, medium, and long-term timeframes. The Ichimoku Kijun at $200.80 acts as immediate support, reinforcing the underlying trend. Near-term support is seen at $200.80 (Ichimoku Kijun), while key support is at $196.13 (MA-50). Immediate resistance is found at $213.50 (recent 52-week high), with further key resistance at $211.58 (HMA).

Overbought signals as bullish momentum tests weekly resistance

Momentum signals on D1 are predominantly bullish, with MACD showing a buy signal and ADX indicating a weak trend at 17.47. Overbought conditions are evident across Stoch RSI (100.00), CCI (160.00), and BBP (9.90), suggesting heightened buying pressure and caution for potential reversals. BBP confirms buyers are currently dominant. The RSI on D1 is at 69.29, close to overbought territory, and the Awesome Oscillator supports the uptrend. DGX is trading at $211.95, up from last week's close of $209.88, a gain of 0.99%. The stock is at the very top of its weekly range, with weekly volatility standing at 7.23%. The weekly tone reflects a steady climb towards resistance with no sharp pullbacks.

High upside probability as indicators forecast consolidation near highs

For the coming week, the expected price range is $210.16 to $216.64, keeping DGX near its annual high and well above the 52-week low of $164.65. W1 indicators (RSI, ADX, MACD, and MA-50) are all flashing buy, so the probability of price increase is very high (more than 80%), with a price decrease looking unlikely. The baseline scenario sees DGX consolidating near current highs between key support and resistance. A bullish breakout above $213.50 could see momentum accelerate towards the higher end of the projected range. If bearish pressures take over and the price slips below $200.80 (Kijun support), a retreat towards $196.13 cannot be ruled out.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Previously it was reported that Quest Diagnostics was exhibiting a bullish technical structure with positive momentum intact. The current analysis adds a new dimension by highlighting emerging factors that could influence trend sustainability, with traders advised to monitor for shifts in momentum and watch for a potential breakout or reversal at key levels.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.